XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows (Parenthetical) - USD ($)
$ in Thousands
Mar. 09, 2023
Mar. 31, 2023
Dec. 31, 2022
Cash and cash equivalents   $ 21,447 $ 6,397
Cash and cash equivalents including cash denominated in foreign currency   1,401 125
Restricted cash and cash equivalents   $ 13,026 $ 10,670
FCRD Acquisition      
Net assets acquired $ 129,511    
Investment portfolio 335,035    
Cash and cash equivalents 1,233    
Other assets 4,513    
Assumed liabilities net 211,270    
Total cash and stock consideration 129,511    
Alcentra acquisition expenses $ 7,565